Literature DB >> 25388976

HIV-serostatus disclosure in the context of free antiretroviral therapy and socio-economic dependency: experiences among women living with HIV in Tanzania.

Leah F Bohle1, Hansjörg Dilger, Uwe Groß.   

Abstract

The worldwide implementation of free antiretroviral therapy (ART) raised great hopes among policy makers and health organisations about the positive changes it would bring about in attitudes and behaviours towards HIV and AIDS, as well as for infected people's lives. A change in illness perception was anticipated, leading to the hypothesis of a possible change in disclosure rates, patterns and the choice of significant others to inform. In the era of free treatment availability in the United Republic of Tanzania, we examined reasons for disclosure and non-disclosure among HIV-seropositive women enrolled on ART and their choice of significant others to inform. In so doing, we contribute to the necessary yet neglected debate about the social impact of ART on the lives of infected women. The study, for which an ethnographic cross-sectional pilot approach was chosen, was conducted at the Care and Treatment Center (CTC) at Bombo Regional Hospital (BRH) in Tanga city, Tanzania. Data presented here derive from participant observation, questionnaires and semi-structured interviews conducted with 59 HIV-seropositive women on ART. Interestingly, and despite treatment availability, the choice of significant others to inform, as well as reasons for disclosure and non-disclosure, mirror findings from previous studies conducted before the introduction of free ART. The main reason for non-disclosure was fear of discrimination. The hope for social, economic or health support was the main motivation for disclosure, followed by the need for a 'clinic companion' in order to receive ART, as requested by hospital staff. Nevertheless, healthcare staff were not unanimous in thinking that disclosure is always beneficial, thus the recommended extent of disclosure varied. ART and concomitant factors were raised as an entirely new and significant reason for disclosure by interviewees. Finally, findings confirm that despite ART, disclosure remains a highly stressful event for women.

Entities:  

Keywords:  AIDS; East Africa; HAART; HIV/AIDS policy; gender; living with antiretroviral therapy; multi-method approach; qualitative

Mesh:

Substances:

Year:  2014        PMID: 25388976     DOI: 10.2989/16085906.2014.952646

Source DB:  PubMed          Journal:  Afr J AIDS Res        ISSN: 1608-5906            Impact factor:   1.300


  3 in total

1.  Barriers to timely disclosure of HIV serostatus: A qualitative study at care and treatment centers in Dar es Salaam, Tanzania.

Authors:  Neelam Ismail; Nancy Matillya; Riaz Ratansi; Columba Mbekenga
Journal:  PLoS One       Date:  2021-08-26       Impact factor: 3.240

2.  The Role of Relationship Dynamics and Gender Inequalities As Barriers to HIV-Serostatus Disclosure: Qualitative Study among Women and Men Living with HIV in Durban, South Africa.

Authors:  Divya S Bhatia; Abigail D Harrison; Muriel Kubeka; Cecilia Milford; Angela Kaida; Francis Bajunirwe; Ira B Wilson; Christina Psaros; Steven A Safren; David R Bangsberg; Jennifer A Smit; Lynn T Matthews
Journal:  Front Public Health       Date:  2017-07-31

Review 3.  Patient-reported barriers and facilitators to antiretroviral adherence in sub-Saharan Africa.

Authors:  Natasha Croome; Monisha Ahluwalia; Lyndsay D Hughes; Melanie Abas
Journal:  AIDS       Date:  2017-04-24       Impact factor: 4.177

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.